Glial levels determine severity of white matter disease in Alzheimer's disease: A neuropathological study of glial changes

Neuropathology and Applied Neurobiology

Volumn 29, Issue 2, 2003, Pages 159-169

  Sjöbeck, Martin ^a   Englund, E ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alzheimer's disease; Astrocytes; Dementia; Glial cells; Morphometry; Neuropathology; Oligodendrocytes; White matter disease

Indexed keywords

AGED; ALZHEIMER DISEASE; ASTROCYTE; BRAIN DISEASE; BRAIN REGION; CELL DISRUPTION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; EVALUATION; FRONTAL CORTEX; FRONTAL LOBE; GLIA CELL; GRAY MATTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGING SYSTEM; MICROSCOPE; MORPHOLOGY; MORPHOMETRICS; NEUROPATHOLOGY; OLIGODENDROGLIA; PARIETAL LOBE; PATHOLOGY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; WHITE MATTER; WHITE MATTER DISEASE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ASTROCYTES; BRAIN; CELL COUNT; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MIDDLE AGED; NEUROGLIA; OLIGODENDROGLIA;

EID: 0037384262     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2990.2003.00456.x     Document Type: Review

References (41)

1. Akiguchi I, Tomimoto H, Suenaga T, Wakita H, Budka H. Alterations in gila and axons in the brains of Binswanger's disease patients. Stroke 1997; 28: 1423-9
2. Almkvist O, Wahlund LO, Andersson-Lundman G, Basun H, Backman L. White-matter hyperintensity and neuropsychological functions in dementia and healthy aging. Arch Neurol 1992; 49: 626-32
3. Bennett DA, Gilley DW, Lee S, Cochran EJ. White matter changes: neurobehavioral manifestations of Binswanger's disease and clinical correlates in Alzheimer's disease. Dementia 1994; 5: 148-52
4. Bennett DA, Gilley DW, Wilson RS, Huckman MS, Fox JH. Clinical correlates of high signal lesions on magnetic resonance imaging in Alzheimer's disease. J Neurol 1992; 239: 186-90
5. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Berl) 1991; 82: 239-59
6. Brown WR, Moody DM, Thore CR, Challa VR. Cerebrovascular pathology in Alzheimer's disease and leukoaraiosis. Ann N Y Acad Sci 2000; 903: 39-45
7. Brun A, Englund E. Regional pattern of degeneration in Alzheimer's disease: neuronal loss and histopathological grading. Histopathology 1981; 5: 549-64
8. Brun A, Englund E. A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol 1986; 19: 253-62
9. Brun A, Gustafson L. The Lund longitudinal dementia study: A 25-year perspective on neuropathology, differential diagnosis and treatment. In Alzheimer's Disease: Advances in Clinical and Basic Research. Eds B Corain, K Iqbal, M Nicolini et al, New York: John Wiley & Sons Ltd. 1993: 3-18
10. Brun A, Liu X, Erikson C. Synapse loss and gliosis in the molecular layer of the cerebral cortex in Alzheimer's disease and in frontal lobe degeneration. Neurodegeneration 1995; 4: 171-7
11. Chui H. Dementia due to subcortical ischemic vascular disease. Clin Cornerstone 2001; 3: 40-51
12. Englund E. Neuropathology of white matter changes in Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord 1998; 9: 6-12
13. Englund E. Neuropathology of white matter disease: parenchymal changes. In The Matter of White Matter Clinical and Pathophysiological Aspects of White Matter Disease Related to Cognitive Decline and Vascular Dementia. Eds L Pantoni, D Inzitari, A Wallin. Utrecht: Academic Pharmaceutical Productions. 2000: 223-46
14. Englund E, Brun A. Frontal lobe degeneration of non-Alzheimer type. IV. White matter changes. Arch Gerontol Geriatr 1987; 6: 235-43
15. Englund E, Brun A. White matter changes in dementia of Alzheimer's type: the difference in vulnerability between cell compartments. Histopathology 1990; 16: 433-9
16. Englund E, Brun A, Alling C. White matter changes in dementia of Alzheimer's type. Biochemical and neuropathological correlates. Brain 1988; 111: 1425-39
17. Englund E, Brun A, Gustafson L. A white-matter disease in dementia of Alzheimer's type - Clinical and neuropathological correlates. Int J Geriatr Psychiatry 1989; 4: 87-102
18. Englund E, Brun A, Persson B. Correlations between histopathologic white matter changes and proton MR relaxation times in dementia. Alzheimer Dis Assoc Disord 1987; 1: 156-70
19. Erkinjuntti T, Ketonen L, Sulkava R, Vuorialho M, Palo J. CT in the differential diagnosis between Alzheimer's disease and vascular dementia. Acta Neurol Scand 1987; 75: 262-70
20. Erkinjuntti T, Sulkava R, Palo J, Ketonen L. White matter low attenuation on CT in Alzheimer's disease. Arch Gerontol Geriatr 1989; 8: 95-104
21. Fazekas F, Kapeller P, Schmidt R, Offenbacher H, Payer F, Fazekas G. The relation of cerebral magnetic resonance signal hyperintensities to Alzheimer's disease. J Neurol Sci 1996; 142: 121-5
22. Grafton ST, Sumi SM, Stimac GK, Alvord EC Jr, Shaw CM, Nochlin D. Comparison of postmortem magnetic resonance imaging and neuropathologic findings in the cerebral white matter. Arch Neurol 1991; 48: 293-8
23. Haglund M, Englund E. Cerebral amyloid angiopathy, white matter lesions and Alzheimer encephalopathy - a histopathological assessment. Dement Geriatr Cogn Disord 2002; 14: 161-6
24. Harris JG, Filley CM. CADASIL: neuropsychological findings in three generations of an affected family. J Int Neuropsychol Soc 2001; 7: 768-74
25. Iwamoto N, Nishiyama E, Ohwada J, Arai H. Distribution of amyloid deposits in the cerebral white matter of the Alzheimer's disease brain: relationship to blood vessels. Acta Neuropathol (Berl) 1997; 93: 334-40
26. Kalimo H, Viitanen M, Amberla K, Juvonen V, Marttila R, Poyhonen M, Rinne JO, Savontaus M, Tuisku S, Winblad B. CADASIL: hereditary disease of arteries causing brain infarcts and dementia. Neuropathol Appl Neurobiol 1999; 25: 257-65
27. Kapeller P, Ropele S, Fazekas F. White matter imaging: technical considerations including histopathological correlation. In The Matter of White Matter. Clinical and Pathophysiological Aspects of White Matter Disease Related to Cognitive Decline and Vascular Dementia. Eds L Pantoni, D Inzitari, A Wallin. Utrecht: Academic Pharmaceutical Productions, 2000; 123-39
28. Kozachuk WE, DeCarli C, Schapiro MB, Wagner EE, Rapoport SI, Horwitz B. White matter hyperintensities in dementia of Alzheimer's type and in healthy subjects without cerebrovascular risk factors. A magnetic resonance imaging study. Arch Neurol 1990; 47: 1306-10
29. Larsson E, Passant U, Sundgren PC, Englund E, Brun A, Lindgren A, Gustafson L. Magnetic resonance imaging and histopathology in dementia, clinically of frontotemporal type. Dement Geriatr Cogn Disord 2000; 11: 123-34
30. Leys D, Soetaert G, Petit H, Fauquette A, Pruvo JP, Steinling M. Periventricular and white matter magnetic resonance imaging hyperintensities do not differ between Alzheimer's disease and normal aging. Arch Neurol 1990; 47: 524-7
31. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41: 479-86
32. Mirsen TR, Lee DH, Wong CJ, Diaz JF, Fox AJ, Hachinski VC, Merskey H. Clinical correlates of white-matter changes on magnetic resonance imaging scans of the brain. Arch Neurol 1991; 48: 1015-21
33. O'Sullivan M, Summers PE, Jones DK, Jarosz JM, Williams SC, Markus HS. Normal-appearing white matter in ischemic leukoaraiosis: a diffusion tensor MRI study. Neurology 2001; 57: 2307-10
34. Schmidt R. Comparison of magnetic resonance imaging in Alzheimer's disease, vascular dementia and normal aging. Eur Neurol 1992; 32: 164-9
35. Skoog I, Berg S, Johansson B, Palmertz B, Andreasson LA. The influence of white matter lesions on neuropsychological functioning in demented and non-demented 85-year-olds. Acta Neurol Stand 1996; 93: 142-8
36. Steingart A, Hachinski VC, Lau C, Fox AJ, Diaz F, Cape R, Lee D, Inzitari D, Merskey H. Cognitive and neurologic findings in subjects with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis). Arch Neurol 1987; 44: 32-5
37. Tsiskaridze A, Shakarishvili R, Janelidze M, Vashadze T, Chikhladze M. Cognitive correlates of leukoaraiosis in the early stages of Alzheimer's disease. Funct Neurol 1998; 13: 17-25
38. Wahlund LO, Basun H, Almkvist O, Andersson-Lundman G, Julin P, Saaf J. White matter hyperintensities in dementia: does it matter? Magn Reson Imaging 1994; 12: 387-94
39. Wallin A, Sjogren M, Edman A, Blennow K, Regland B. Symptoms, vascular risk factors and blood-brain barrier function in relation to CT white-matter changes in dementia. Eur Neurol 2000; 44: 229-35
40. Vermeulen R, Scheltens P. Heterogeneity in Alzheimer's disease: the role of white matter changes. In The Matter of White Matter. Clinical and Pathophysiological Aspects of White Matter Disease Related to Cognitive Decline and Vascular Dementia. Eds L Pantoni, D Inzitari, A Wallin. Utrecht: Academic Pharmaceutical Productions, 2000; 109-20
41. Xu J, Chen S, Ahmed SH, Chen H, Ku G, Goldberg MP, Hsu CY. Amyloid-beta peptides are cytotoxic to oligodendrocytes. J Neurosci 2001; 21: RC118